Young Kwang Chae

Young Kwang Chae

UNVERIFIED PROFILE

Are you Young Kwang Chae?   Register this Author

Register author
Young Kwang Chae

Young Kwang Chae

Publications by authors named "Young Kwang Chae"

Are you Young Kwang Chae?   Register this Author

89Publications

1848Reads

44Profile Views

Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial.

J Clin Endocrinol Metab 2019 Dec;104(12):6193-6200

Developmental Therapeutics Program, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2019-00600DOI Listing
December 2019

Clinical and Immunological Implications of Frameshift Mutations in Lung Cancer.

J Thorac Oncol 2019 Oct 22;14(10):1807-1817. Epub 2019 Jun 22.

Leonard M. Miller School of Medicine, University of Miami, Miami, Florida; Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.06.016DOI Listing
October 2019

Real-World Clinical and Economic Outcomes and the Role of Bevacizumab in Patients With Non-Small-Cell Lung Cancer With Liver Metastases.

J Oncol Pract 2019 Oct 11;15(10):e878-e887. Epub 2019 Sep 11.

Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.19.00166DOI Listing
October 2019

Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer.

Oncologist 2019 06 13;24(6):820-828. Epub 2019 Mar 13.

Developmental Therapeutics Program of Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2018-0433DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656496PMC
June 2019

Association of Tumor Mutational Burden With DNA Repair Mutations and Response to Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer.

Clin Lung Cancer 2019 03 25;20(2):88-96.e6. Epub 2018 Sep 25.

Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2018.09.008DOI Listing
March 2019

Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions.

J Thorac Oncol 2019 01 6;14(1):16-24. Epub 2018 Oct 6.

Northwestern University Feinberg School of Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183317
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.09.022DOI Listing
January 2019

Deep and Durable Response With Combination CTLA-4 and PD-1 Blockade in Mismatch Repair (MMR)-proficient Endometrial Cancer.

J Immunother 2019 Feb/Mar;42(2):51-54

Northwestern University Feinberg School of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000244DOI Listing
September 2018

Developing a Predictive Model for Clinical Outcomes of Advanced Non-Small Cell Lung Cancer Patients Treated With Nivolumab.

Clin Lung Cancer 2018 05 21;19(3):280-288.e4. Epub 2017 Dec 21.

Divisions of Hematology and Medical Oncology, Departments of Medicine, Miller School of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.12.007DOI Listing
May 2018

Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC).

J Immunother Cancer 2018 05 16;6(1):39. Epub 2018 May 16.

Developmental Therapeutics Program of the Division of Hematology Oncology, Early Phase Clinical Trials Unit, 645 N. Michigan Avenue, Suite 1006, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-018-0349-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5956851PMC
May 2018

Molecular Biomarkers of Primary and Acquired Resistance to T-Cell-Mediated Immunotherapy in Cancer: Landscape, Clinical Implications, and Future Directions.

Oncologist 2018 04 14;23(4):410-421. Epub 2017 Dec 14.

Developmental Therapeutics Program of Division of Hematology Oncology, Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0354DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896702PMC
April 2018

Immune checkpoint pathways in non-small cell lung cancer.

Ann Transl Med 2018 Mar;6(5):88

Developmental Therapeutics Program of the Division of Hematology Oncology, Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2017.09.30DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890048PMC
March 2018

Cancer immunotherapy in a neglected population: The current use and future of T-cell-mediated checkpoint inhibitors in organ transplant patients.

Cancer Treat Rev 2018 Feb 8;63:116-121. Epub 2017 Dec 8.

Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03057372173020
Publisher Site
http://dx.doi.org/10.1016/j.ctrv.2017.12.004DOI Listing
February 2018

Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support.

Mol Cancer Ther 2017 Dec;16(12):2645-2655

Developmental Therapeutics Program, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-17-0597DOI Listing
December 2017

A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer.

Oncotarget 2017 Oct 13;8(51):89284-89306. Epub 2017 Jun 13.

Developmental Therapeutics Program, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/18467
Publisher Site
http://dx.doi.org/10.18632/oncotarget.18467DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687690PMC
October 2017

Pseudoprogression in microsatellite instability-high colorectal cancer during treatment with combination T cell mediated immunotherapy: a case report and literature review.

Oncotarget 2017 Aug 3;8(34):57889-57897. Epub 2017 Jun 3.

Developmental Therapeutics Program of the Division of Hematology Oncology, Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.18361DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593692PMC
August 2017

Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue versus Circulating Tumor DNA in Breast Cancer.

Mol Cancer Ther 2017 07 26;16(7):1412-1420. Epub 2017 Apr 26.

Developmental Therapeutics Program of Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-17-0061DOI Listing
July 2017

Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis.

Cancer Manag Res 2017 14;9:207-213. Epub 2017 Jun 14.

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
https://www.dovepress.com/clinical-features-diagnostic-chall
Publisher Site
http://dx.doi.org/10.2147/CMAR.S136818DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476791PMC
June 2017

Developmental Therapeutics Implications of Next-Generation Sequencing in Human Herpesvirus 8-Negative Castleman Disease.

JAMA Dermatol 2017 05;153(5):381-382

Developmental Therapeutics Program, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois2Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamadermatol.2016.5555DOI Listing
May 2017

Nodal Signaling as a Developmental Therapeutics Target in Oncology.

Mol Cancer Ther 2017 05;16(5):787-792

Developmental Therapeutics Program, Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Olson Pavilion, Chicago, Illinois.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0215DOI Listing
May 2017

Wnt/beta-catenin pathway: modulating anticancer immune response.

J Hematol Oncol 2017 05 5;10(1):101. Epub 2017 May 5.

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-017-0471-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420131PMC
May 2017

Recent Advances and Future Strategies for Immune-Checkpoint Inhibition in Small-Cell Lung Cancer.

Clin Lung Cancer 2017 03 9;18(2):132-140. Epub 2016 Jul 9.

Developmental Therapeutics Program of the Division of Hematology Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL; Division of Hematology Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL; The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.07.004DOI Listing
March 2017

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions.

Oncotarget 2017 Feb;8(7):12417-12432

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Chicago, United States of America.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.13778DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355355PMC
February 2017

Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development.

Cancer Treat Rev 2017 Feb 5;53:111-119. Epub 2017 Jan 5.

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Chicago, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2016.12.010DOI Listing
February 2017

A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes.

Cancer Immunol Immunother 2017 01 19;66(1):25-32. Epub 2016 Oct 19.

Developmental Therapeutics Program of the Division of Hematology/Oncology, Northwestern University, Chicago, IL, 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-016-1913-7DOI Listing
January 2017

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives.

Drug Des Devel Ther 2016 29;10:873-84. Epub 2016 Feb 29.

Northwestern Medicine Developmental Therapeutics Institute, Robert H Lurie Comprehensive Cancer Center of Northwestern University, IL, USA; Division of Hematology and Oncology, Feinberg School of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/DDDT.S93459DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4778792PMC
October 2016

Biomarkers for PD-1/PD-L1 Blockade Therapy in Non-Small-cell Lung Cancer: Is PD-L1 Expression a Good Marker for Patient Selection?

Clin Lung Cancer 2016 09 6;17(5):350-361. Epub 2016 Apr 6.

Developmental Therapeutics Program of the Division of Hematology Oncology, Department of Medicine, Northwestern Medicine Developmental Therapeutics Institute, Northwestern University, Chicago, IL; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Northwestern University Feinberg School of Medicine, Chicago, IL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.03.011DOI Listing
September 2016

FGFR3-TACC3 fusion in solid tumors: mini review.

Oncotarget 2016 08;7(34):55924-55938

Developmental Therapeutics Program, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.10482DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342462PMC
August 2016

The challenge of developmental therapeutics for adrenocortical carcinoma.

Oncotarget 2016 Jul;7(29):46734-46749

Northwestern Medicine Developmental Therapeutics Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.8774DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216833PMC
July 2016

EGFR Fusions as Novel Therapeutic Targets in Lung Cancer.

Cancer Discov 2016 06 21;6(6):601-11. Epub 2016 Apr 21.

Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee. Addario Lung Cancer Medical Institute, Cambridge, Massachusetts. Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-16-0075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893907PMC
June 2016

Is Personalized Medicine Here?

Oncology (Williston Park) 2016 Apr;30(4):293-303, 307

View Article

Download full-text PDF

Source
April 2016

Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling.

Oncotarget 2015 Nov;6(35):37117-34

Northwestern Medicine Developmental Therapeutics Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.5076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741919PMC
November 2015

The effect of calcium channel blockers on the outcome of acute myeloid leukemia.

Leuk Lymphoma 2014 Dec 29;55(12):2822-9. Epub 2014 Apr 29.

Division of Cancer Medicine, The University of Texas M. D. Anderson Medical Center , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.901513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4213321PMC
December 2014

Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma.

J Natl Cancer Inst 2014 May 9;106(5). Epub 2014 May 9.

Affiliations of authors: Department of Gastrointestinal Medical Oncology (AOK, MMH, YKC, SC, HM H, KR, JLA, RW), Department of Biostatistics (LX, JSM), Department of Systems Biology (JSL), Department of Surgical Oncology (JNV, TA, CC, SAC), Department of Radiation Oncology (SK), Department of Interventional Radiology (MW), and Department of Pathology (AR), University of Texas MD Anderson Cancer Center, Houston, TX; Department of Hepatology, Baylor College of Medicine, Houston, TX (JMV, PJ).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4085880PMC
May 2014

The risk for coronary heart disease according to insulin resistance with and without type 2 diabetes.

Endocr Res 2013 20;38(4):195-205. Epub 2013 Feb 20.

Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, Baylor College of Medicine , Houston, Texas , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/07435800.2013.766800DOI Listing
April 2014

Implications of functional proteomics in breast cancer.

Oncologist 2014 Apr 24;19(4):328-35. Epub 2014 Mar 24.

Division of Cancer Medicine and Departments of Breast Medical Oncology and Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0437DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3983827PMC
April 2014

Two birds with one stone: octreotide treatment for acromegaly and breast cancer.

J Clin Oncol 2013 Aug 24;31(23):e398-400. Epub 2013 Jun 24.

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.46.6383DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878051PMC
August 2013

Association between common allergic symptoms and cancer in the NHANES III female cohort.

PLoS One 2012 18;7(9):e42896. Epub 2012 Sep 18.

Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0042896PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445609PMC
March 2013

Repeat colonoscopy's value in gastrointestinal bleeding.

World J Gastrointest Endosc 2013 Feb;5(2):56-61

Parit Mekaroonkamol, Kimberly Jegel Chaput, Pojnicha Mekaroonkamol, Sherry Pomerantz, Department of Internal Medicine, Albert Einstein Medical Center, Philadelphia, PA 19141, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4253/wjge.v5.i2.56DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574613PMC
February 2013

Reduced risk of breast cancer recurrence in patients using ACE inhibitors, ARBs, and/or statins.

Cancer Invest 2011 Nov 21;29(9):585-93. Epub 2011 Sep 21.

Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/07357907.2011.616252DOI Listing
November 2011

Financial conflicts of interest in economic analyses in oncology.

Am J Clin Oncol 2011 Oct;34(5):524-8

Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e3181f4799bDOI Listing
October 2011

Dose-related effect of statins in venous thrombosis risk reduction.

Am J Med 2011 Sep 21;124(9):852-9. Epub 2011 Jul 21.

Department of Medicine, Albert Einstein Medical Center, Philadelphia, PA 19141, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2011.04.019DOI Listing
September 2011

Diet in infancy and later signs of beta-cell autoimmunity.

N Engl J Med 2011 03;364(9):879-80; author reply 880

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1100063DOI Listing
March 2011

Relation between common allergic symptoms and coronary heart disease among NHANES III participants.

Am J Cardiol 2010 Oct 11;106(7):984-7. Epub 2010 Aug 11.

Department of Medicine, Albert Einstein Medical Center, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2010.05.029DOI Listing
October 2010

Targeting epidermal growth factor receptor in head and neck cancer: lessons learned from cetuximab.

Exp Biol Med (Maywood) 2010 Aug 18;235(8):907-20. Epub 2010 Jun 18.

Department of Otolaryngology - Head and Neck Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1258/ebm.2009.009181DOI Listing
August 2010

Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: a systematic review.

Breast Cancer Res Treat 2010 Jun 30;121(2):273-9. Epub 2010 Mar 30.

Division of Hematology, Oncology and Transplantation, University of Minnesota, 14-142 PWB, 420 Delaware Street SE, MMC 480, Minneapolis, MN 55455, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-010-0870-7DOI Listing
June 2010

Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer.

PLoS One 2009 Aug 5;4(8):e6523. Epub 2009 Aug 5.

Department of Medicine, Albert Einstein Medical Center, Philadelphia, Pennsylvania; United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006523PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715882PMC
August 2009

Genomewide association studies of stroke.

N Engl J Med 2009 Aug;361(7):722; author reply 722

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc091089DOI Listing
August 2009

Adverse outcomes associated with use of proton pump inhibitors and clopidogrel.

JAMA 2009 Jul;302(1):29; author reply 31

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2009.896DOI Listing
July 2009

Current status of experimental therapeutics for prostate cancer.

Cancer Lett 2008 Aug 28;266(2):116-34. Epub 2008 Apr 28.

Department of Otolaryngology and Head and Neck Cancer Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21231, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2008.02.065DOI Listing
August 2008

Role of human aquaporin 5 in colorectal carcinogenesis.

Am J Pathol 2008 Aug 26;173(2):518-25. Epub 2008 Jun 26.

The Head and Neck Cancer Research Division, Department of Otolaryngology, The Johns Hopkins University, CRBII, 5M03, 1550 Orleans St., Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2353/ajpath.2008.071198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2475788PMC
August 2008

Methylation of the DFNA5 increases risk of lymph node metastasis in human breast cancer.

Biochem Biophys Res Commun 2008 May 17;370(1):38-43. Epub 2008 Mar 17.

Department of Otolaryngology, Head and Neck Cancer Research Institute, Johns Hopkins University, 1550 Orleans Street 5N.03, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2008.03.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094717PMC
May 2008

Membrane trafficking of AQP5 and cAMP dependent phosphorylation in bronchial epithelium.

Biochem Biophys Res Commun 2008 Feb 26;366(2):321-7. Epub 2007 Nov 26.

Department of Otolaryngology, Johns Hopkins University, 1550 Orleans St. 574A, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2007.11.078DOI Listing
February 2008

Epigenetic silencing of human T (brachyury homologue) gene in non-small-cell lung cancer.

Biochem Biophys Res Commun 2008 Jan 31;365(2):221-6. Epub 2007 Oct 31.

Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, 1550 Orleans Street, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2007.10.144DOI Listing
January 2008

A promoter methylation pattern in the N-methyl-D-aspartate receptor 2B gene predicts poor prognosis in esophageal squamous cell carcinoma.

Clin Cancer Res 2007 Nov;13(22 Pt 1):6658-65

Department of Otolaryngology, Head and Neck Cancer Research Division, Johns Hopkins University, 1550 Orleans Street, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-1178DOI Listing
November 2007

Early supplementation with high-dose vitamin A in The Gambia.

Lancet 2007 Sep;370(9592):1030; author reply 1030-1

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(07)61468-8DOI Listing
September 2007

Folic acid and prevention of colorectal adenomas.

JAMA 2007 Sep;298(12):1397; author reply 1397

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.298.12.1397-aDOI Listing
September 2007

Risk of cancer from blood donated by people with cancer.

Lancet 2007 Aug;370(9587):563; author reply 563-4

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(07)61286-0DOI Listing
August 2007